Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (LucaVax)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2012 by Kael-GemVax Co., Ltd..
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
Quintiles, Inc.
Information provided by (Responsible Party):
Kael-GemVax Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01579188
First received: April 13, 2012
Last updated: April 18, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: May 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)